AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

IDOX PLC

Regulatory Filings Jan 23, 2020

7699_rns_2020-01-23_14d174b7-87e0-431b-99db-9972007c237e.html

Regulatory Filings

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 6515A

IDOX PLC

23 January 2020

23 January 2020

Idox plc

('Idox' or the 'Group' or the 'Company')

Change of Adviser and Notice of Results

ldox plc (AIM: IDOX), a leading supplier of specialist information management software and solutions to the public and asset intensive sectors, is pleased to announce that it has appointed Peel Hunt LLP to act as the Company's Nominated Advisor and sole corporate broker with effect from 23 January 2020.

The Group expects to announce its results for the twelve months ended 31 October 2019 on 11 February 2020.

An analyst presentation, hosted by David Meaden, Chief Executive Officer and Rob Grubb, Chief Financial Officer, will be held at 9.30am on Tuesday, 11th February 2020, at the offices of MHP Communications, located at 6 Agar Street, London, WC2N 4HN.  Please email [email protected] if you wish to register your interest in attending.

-Ends-

Enquiries:

Idox plc +44 (0) 870 333 7101
David Meaden, Chief Executive
Rob Grubb, Chief Financial Officer
Peel Hunt LLP (NOMAD and Broker) +44 (0) 20 7418 8900
Edward Knight
Nick Prowting
James Steel
MHP Communications + 44 (0) 203 128 8100
Reg Hoare [email protected]

About Idox plc

For more information see www.idoxplc.com @Idoxgroup 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

MSCKZGZMNZZGGZM

Talk to a Data Expert

Have a question? We'll get back to you promptly.